Works matching IS 03065251 AND DT 2018 AND VI 84 AND IP 4


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8

    Nutraceuticals: opening the debate for a regulatory framework.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 659, doi. 10.1111/bcp.13496
    By:
    • Santini, Antonello;
    • Cammarata, Silvia Miriam;
    • Capone, Giacomo;
    • Ianaro, Angela;
    • Tenore, Gian Carlo;
    • Pani, Luca;
    • Novellino, Ettore
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488
    By:
    • Nebot, Noelia;
    • Arkenau, Hendrik‐Tobias;
    • Infante, Jeffrey R.;
    • Chandler, Jason C.;
    • Weickhardt, Andrew;
    • Lickliter, Jason D.;
    • Sarantopoulos, John;
    • Gordon, Michael S.;
    • Mak, Gabriel;
    • St‐Pierre, Annie;
    • Tang, Lihua;
    • Mookerjee, Bijoyesh;
    • Carson, Stanley W.;
    • Hayes, Siobhan;
    • Grossmann, Kenneth F.
    Publication type:
    Article
    17
    18
    19
    20
    21

    Issue Information.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 607, doi. 10.1111/bcp.13410
    Publication type:
    Article
    22